Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ern Yu Tan

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Cancers|June 26, 2026
Retrospective Cohort Study: Extracting Coexisting Background Breast-Lesion Features from Stage I-III Invasive Breast CancerRyan Jak Yang Lim, Phyu Nitar, Kah Weng Lau, et al.
Nature Communications|October 28, 2015
IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxelZhen Ning Wee, Siti Maryam J M Yatim, Vera K Kohlbauer, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2022
IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancerLi-Teng Ong, Wee Chyan Lee, Shijun Ma, et al.
Oncogene|December 20, 2017
GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancersSuhail Ahmed Kabeer Rasheed, Hui Sun Leong, Manikandan Lakshmanan, et al.
International Journal of Molecular Sciences|January 21, 2023
Profiling Microbial Communities in Idiopathic Granulomatous MastitisSeeu Si Ong, Jia Xu, Choon Kiat Sim, et al.
Breast Cancer Research and Treatment|March 26, 2021
DNA methylation and breast cancer-associated variantsPeh Joo Ho, Rajkumar Dorajoo, Ivna Ivanković, et al.
Cancer Medicine|December 22, 2016
Outcome after neoadjuvant chemotherapy in Asian breast cancer patientsLi Yan Lim, Hui Miao, Joline S J Lim, et al.
Nature Medicine|October 3, 2017
Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrenceJian Yuan Goh, Min Feng, Wenyu Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Significant Effect of Polymorphisms in <i>CYP2D6</i> on Response to Tamoxifen Therapy for Breast Cancer: A Prospective Multicenter StudyHitoshi Zembutsu, Seigo Nakamura, Sadako Akashi-Tanaka, et al.
Nature Communications|April 28, 2023
Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesisJieqiong Zhang, Zhenhua Hu, Hwa Hwa Chung, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Cancers|June 26, 2026
Retrospective Cohort Study: Extracting Coexisting Background Breast-Lesion Features from Stage I-III Invasive Breast CancerRyan Jak Yang Lim, Phyu Nitar, Kah Weng Lau, et al.
Nature Communications|October 28, 2015
IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxelZhen Ning Wee, Siti Maryam J M Yatim, Vera K Kohlbauer, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2022
IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancerLi-Teng Ong, Wee Chyan Lee, Shijun Ma, et al.
Oncogene|December 20, 2017
GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancersSuhail Ahmed Kabeer Rasheed, Hui Sun Leong, Manikandan Lakshmanan, et al.
International Journal of Molecular Sciences|January 21, 2023
Profiling Microbial Communities in Idiopathic Granulomatous MastitisSeeu Si Ong, Jia Xu, Choon Kiat Sim, et al.
Breast Cancer Research and Treatment|March 26, 2021
DNA methylation and breast cancer-associated variantsPeh Joo Ho, Rajkumar Dorajoo, Ivna Ivanković, et al.
Cancer Medicine|December 22, 2016
Outcome after neoadjuvant chemotherapy in Asian breast cancer patientsLi Yan Lim, Hui Miao, Joline S J Lim, et al.
Nature Medicine|October 3, 2017
Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrenceJian Yuan Goh, Min Feng, Wenyu Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Significant Effect of Polymorphisms in <i>CYP2D6</i> on Response to Tamoxifen Therapy for Breast Cancer: A Prospective Multicenter StudyHitoshi Zembutsu, Seigo Nakamura, Sadako Akashi-Tanaka, et al.
Nature Communications|April 28, 2023
Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesisJieqiong Zhang, Zhenhua Hu, Hwa Hwa Chung, et al.
Pageof 9